Insider · CIK 0001310204
Andrew D Dickinson
cfoofficer
Files at GILD (GILEAD SCIENCES, INC.). First filing Dec 3, 2024, latest Sep 16, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 9
$0 bought, $55M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GILD: GILEAD SCIENCES, INC.
GILDOct 9, 2026 · close 151.17
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 34Weak | GILEAD SCIENCES, INC. | $436k 3,000 shares | -2% | - | |
| 16Weak | GILEAD SCIENCES, INC. | $276k 2,500 shares | -1% | - | |
| 12Weak | GILEAD SCIENCES, INC. | $2.1M 17,929 shares | -10% | - | |
| 15Weak | GILEAD SCIENCES, INC. | $260k 2,500 shares | -1% | - | |
| 22Weak | GILEAD SCIENCES, INC. | $14M 137,676 shares | -45% | - | |
| 32Weak | GILEAD SCIENCES, INC. | $14M 142,180 shares | -52% | - | |
| 15Weak | GILEAD SCIENCES, INC. | $228k 2,500 shares | -2% | - | |
| 24Weak | GILEAD SCIENCES, INC. | $782k 8,500 shares | -6% | - | |
| 47Moderate | GILEAD SCIENCES, INC. | $23M 248,645 shares | -64% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -3,000 | $145.29 | $436k | 164,096 | 26 d ago |
| Sep 10, 2026 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock | +2,797 | - | - | 168,443 | 31 d ago |
| Sep 10, 2026 | GILD GILEAD SCIENCES, INC. | FTax withholding Common Stock | -1,347 | $144.81 | $195k | 167,096 | 31 d ago |
| Sep 10, 2026 | GILD GILEAD SCIENCES, INC. | MOption exercise Restricted Stock Unitderivative | -2,797 | - | - | 25,054 | 31 d ago |
| Mar 17, 2025 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -2,500 | $110.53 | $276k | 170,674 | Mar 18, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +4,916 | $63.91 | $314k | 173,977 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +13,013 | $63.91 | $832k | 186,990 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -4,916 | $117.30 | $577k | 182,074 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -13,013 | $118.50 | $1.5M | 169,061 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +7,968 | - | - | 177,029 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | FTax withholding Common Stock10b5-1 | -3,855 | $117.21 | $452k | 173,174 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -4,916 | $0.00 | $0 | 13,013 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -13,013 | $0.00 | $0 | 0 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Restricted Stock Unitderivative10b5-1 | -7,968 | - | - | 27,519 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Non-qualified Stock Option (Right to Buy)derivative10b5-1 | +49,020 | $0.00 | $0 | 49,020 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Restricted Stock Unitderivative10b5-1 | +11,090 | - | - | 38,609 | Mar 12, 2025 |
| Feb 18, 2025 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -2,500 | $104.09 | $260k | 169,061 | Feb 19, 2025 |
| Feb 12, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +77,691 | $63.91 | $5.0M | 248,914 | Feb 13, 2025 |
| Feb 12, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +26,175 | $57.92 | $1.5M | 275,089 | Feb 13, 2025 |
| Feb 12, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +15,600 | $80.72 | $1.3M | 290,689 | Feb 13, 2025 |
| Feb 12, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +18,210 | $83.49 | $1.5M | 308,899 | Feb 13, 2025 |
| Feb 12, 2025 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -137,676 | $102.22 | $14M | 171,223 | Feb 13, 2025 |
| Feb 12, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -77,691 | $0.00 | $0 | 17,929 | Feb 13, 2025 |
| Feb 12, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -26,175 | $0.00 | $0 | 78,515 | Feb 13, 2025 |
| Feb 12, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -15,600 | $0.00 | $0 | 0 | Feb 13, 2025 |
| Feb 12, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -18,210 | $0.00 | $0 | 0 | Feb 13, 2025 |
| Feb 4, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Common Stock | +19,793 | $0.00 | $0 | 149,666 | Feb 6, 2025 |
| Feb 4, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Common Stock | +64,695 | $0.00 | $0 | 214,361 | Feb 6, 2025 |
| Feb 4, 2025 | GILD GILEAD SCIENCES, INC. | FTax withholding Common Stock | -43,138 | $97.99 | $4.2M | 171,223 | Feb 6, 2025 |
| Jan 31, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +26,170 | $57.92 | $1.5M | 156,043 | Feb 3, 2025 |
| Jan 31, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +71,850 | $72.34 | $5.2M | 227,893 | Feb 3, 2025 |
| Jan 31, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +44,160 | $65.38 | $2.9M | 273,053 | Feb 3, 2025 |
| Jan 31, 2025 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -142,180 | $97.22 | $14M | 129,873 | Feb 3, 2025 |
| Jan 31, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -26,170 | $0.00 | $0 | 104,690 | Feb 3, 2025 |
| Jan 31, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -71,850 | $0.00 | $0 | 0 | Feb 3, 2025 |
| Jan 31, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -44,160 | $0.00 | $0 | 0 | Feb 3, 2025 |
| Jan 15, 2025 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -2,500 | $91.35 | $228k | 129,873 | Jan 16, 2025 |
| Dec 16, 2024 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -8,500 | $91.96 | $782k | 132,373 | Dec 17, 2024 |
| Dec 10, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock | +3,640 | - | - | 142,559 | Dec 11, 2024 |
| Dec 10, 2024 | GILD GILEAD SCIENCES, INC. | FTax withholding Common Stock | -1,686 | $92.34 | $156k | 140,873 | Dec 11, 2024 |
| Dec 10, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Restricted Stock Unitderivative | -3,640 | - | - | 35,487 | Dec 11, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +18,630 | $73.77 | $1.4M | 157,549 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +26,170 | $57.92 | $1.5M | 183,719 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +33,660 | $68.75 | $2.3M | 217,379 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +60,885 | $71.91 | $4.4M | 278,264 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +43,340 | $72.70 | $3.2M | 321,604 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +65,960 | $72.70 | $4.8M | 387,564 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -120,715 | $92.77 | $11M | 266,849 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -127,930 | $92.76 | $12M | 138,919 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -26,170 | $0.00 | $0 | 130,860 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -18,630 | $0.00 | $0 | 0 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -33,660 | $0.00 | $0 | 0 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -60,885 | $0.00 | $0 | 0 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -43,340 | $0.00 | $0 | 0 | Dec 3, 2024 |
| Nov 29, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative10b5-1 | -65,960 | $0.00 | $0 | 0 | Dec 3, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.